Cynata Therapeutics Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
602.40
447.90
280.70
280.00
280.00
Gross Income
602.40
447.90
280.70
280.00
280.00
SG&A Expense
2,545.00
3,639.00
5,900.70
6,052.60
5,851.10
EBIT
3,147.40
4,087.00
6,181.50
6,332.60
6,131.00
Non Operating Income/Expense
-
4.00
161.70
64.10
93.30
Pretax Income
3,064.70
3,993.70
5,872.10
6,302.40
5,894.80
Income Tax
25.10
281.60
932.60
1,748.90
1,328.70
Consolidated Net Income
3,039.70
3,712.10
4,939.50
4,553.50
4,566.10
Net Income
3,039.70
3,712.10
4,939.50
4,553.50
4,566.10
Net Income After Extraordinaries
3,039.70
3,712.10
4,939.50
4,553.50
4,566.10
Net Income Available to Common
3,039.70
3,712.10
4,939.50
4,553.50
4,566.10
EPS (Basic)
0.07
0.06
0.07
0.06
0.05
Basic Shares Outstanding
44,942.40
60,615.90
72,446.60
80,061.20
90,609.00
EPS (Diluted)
0.07
0.06
0.07
0.06
0.05
Diluted Shares Outstanding
44,942.40
60,615.90
72,446.60
80,061.20
90,609.00
EBITDA
3,147.20
3,639.00
5,900.80
6,052.60
5,851.10
Non-Operating Interest Income
82.70
89.30
147.70
94.20
142.90
About Cynata Therapeutics
View Profile
